{"title":"甲状腺弥漫性[18F] AlF-NOTA-FAPI-04摄取在PET/CT上的临床意义","authors":"Ying Kou, Wei Diao, Zhuzhong Cheng, Yutang Yao","doi":"10.1186/s13550-025-01231-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many patients undergoing [<sup>18</sup>F] AlF-NOTA-FAPI-04 (<sup>18</sup>F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse <sup>18</sup>F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent <sup>18</sup>F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared <sup>18</sup>F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of <sup>18</sup>F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on <sup>18</sup>F-FAPI PET/CT.</p><p><strong>Results: </strong>A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in <sup>18</sup>F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, p = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, p = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all p > 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (p > 0.05).</p><p><strong>Conclusions: </strong>Diffuse uptake of <sup>18</sup>F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on <sup>18</sup>F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"15 1","pages":"47"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12032088/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical significance of diffuse [<sup>18</sup>F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging.\",\"authors\":\"Ying Kou, Wei Diao, Zhuzhong Cheng, Yutang Yao\",\"doi\":\"10.1186/s13550-025-01231-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Many patients undergoing [<sup>18</sup>F] AlF-NOTA-FAPI-04 (<sup>18</sup>F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse <sup>18</sup>F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent <sup>18</sup>F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared <sup>18</sup>F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of <sup>18</sup>F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on <sup>18</sup>F-FAPI PET/CT.</p><p><strong>Results: </strong>A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in <sup>18</sup>F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, p = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, p = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all p > 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (p > 0.05).</p><p><strong>Conclusions: </strong>Diffuse uptake of <sup>18</sup>F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on <sup>18</sup>F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.</p>\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":\"15 1\",\"pages\":\"47\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12032088/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-025-01231-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-025-01231-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging.
Background: Many patients undergoing [18F] AlF-NOTA-FAPI-04 (18F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse 18F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent 18F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared 18F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of 18F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on 18F-FAPI PET/CT.
Results: A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in 18F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, p = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, p = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all p > 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (p > 0.05).
Conclusions: Diffuse uptake of 18F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on 18F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.